Upcoming Event

Second Annual London Macro Conference

11/13/2018 To 11/14/2018 London

Since our founding, our the Macro Research team has built its research product on four basic principles:
Utility. Humility. Simplicity. Quality. Coupling rigorous analytical process with intellectual flexibility, Strategas seeks to provide clear and concise research that yields timely and actionable investment conclusions.

The Strategas Capital Markets team leverages decades of experience and the full breadth of our macro research capabilities to provide corporate executives, and their boards, with actionable analytics, good counsel, innovative strategies and superior execution in an increasingly competitive and dynamic marketplace.

The best research is worthless unless it leads to an actionable conclusion. Strategas' “first principles” approach to research and idea generation has generated significant client demand such that the Firm formed Strategas Asset Management,
a registered investment advisor, to offer a range of managed account strategies to leverage the thematic investment conclusions and actionable ideas of the Firm’s macro research teams.

Turning Insight into Action
Our Firm

Our Firm

Strategas is an institutional brokerage and advisory firm serving clients in more than twenty countries around the world. Founded in 2006 by Jason DeSena Trennert, Nicholas Bohnsack, and Don Rissmiller, the Firm provides Macro Research and Capital Markets & Corporate Advisory services to institutional managers and corporate executives and through Strategas Asset Management manages a suite of macro thematic investment strategies by institutional mandate and for ultra and high-net-worth investors.
Today’s Research

Policy Research

10/19/2018 Clifton

DC Weekly Update

Today’s Research

Weekend Reader

10/19/2018 Research Team

Charts of the Week

Today’s Research

Technical Research

10/19/2018 Verrone

Video Update... Where Do We Stand?

In Today’s Video… 1) Where Do We Stand? 2) Market Posture More Defensive vs. January 3) Credit OK 4) Healthcare Remains Leadership 5) Wouldn’t Short E.M. Here
Today’s Research

Economics

10/19/2018 Rissmiller

Continued Global "Second-Derivative" Concerns

Real GDP in China slowed to 6.5% y/y in 3Q, which, while expected, still reinforces the “second-derivative” concerns as we start 4Q and begin to look forward to 2019.  Worse/better is mattering more than bad/good. The budget debate in Italy also continues to heat up, Spain’s budget is additionally in focus, and Brexit is still being negotiated. Saudi/Turkey tension has increased, but thus far ... 
Today’s Research

Strategy

10/19/2018 Trennert

Rorschach Test For Reflation

In today’s Investment Strategy Viewpoint, I take stock of the changing investment landscape and stories of the last few weeks that lead me to believe we may be in the early stages of global reflation and a realization among policy makers, in some cases 30 years in the making, that financial repression has its political and economic limits.